🔗 Share this article

An underground economy for unlicensed slimming drugs is propelled by TikTok fitness influencers and vendors on communication apps, according to new investigations.

Experimental Drug Acquiring Popularity Online

Retatrutide, which is still in research studies, is being promoted by social media influencers for its alleged weight-reducing effects. Followers are urged to contact these accounts directly for source information, while also obtaining promotional offers.

Active Commerce on Messaging Platforms

Separately, a robust trade exists on messaging services, where communities with numerous of participants share “before and after” photos, administration instructions and claims of next-day British shipping. Sellers market the substance there before directing buyers to WhatsApp for transactions.

Understanding Retatrutide

This medication is an investigational injectable developed by US drugmaker Eli Lilly. The treatment targets three intestinal hormones – glucagon-like peptide-1, GIP and glucagon. Preliminary studies suggest it could help patients reduce up to a quarter of their body weight. Nicknamed the “triple G”, the drug is being promoted online as the successor to Ozempic.

Healthcare Professionals Express Concerns

Nevertheless, physicians and pharmacists have warned that the sale of what remains an unlicensed drug in the UK is worrisome and could result in individuals injecting products of unknown origin.

Several experts said the popularity for retatrutide could be linked to the rising price of licensed weight loss treatments such as Mounjaro.

Regulatory Position and Implementation

Marketing retatrutide on TikTok or Telegram is prohibited in the United Kingdom, as it is an unlicensed drug that cannot be marketed or distributed for personal consumption under the Human Medicines Regulations 2012.

Some influencers attempt to sidestep the regulations by calling to the substance as a “research chemical” or describing it as “not for human consumption”. The substance is not a restricted substance, but advertising and distribution can still violate pharmaceutical, marketing, and consumer regulations, potentially leading to penalties, legal action or prison.

Platform Response and Material Elimination

According to TikTok, the service has taken down problematic content and banned related hashtags and query recommendations. The organization stated it was dedicated to maintaining the service secure and allocating resources in strengthening enforcement strategies.

Online Marketplace Operations

Investigations also found groups with up to 9,000 members marketing the experimental drug using the platform's built-in discovery tool, which operates like a online catalog. Entering “retatrutide” instantly displays channels with thousands of users, filled with images of slimming results, glowing reviews and step-by-step guides for mixing or injecting at home.

Within minutes of entering one community, a vendor posted contact information, where the majority of transactions take place. The vendor provided an instruction manual and promised shipping within 48 hours. When questioned whether the product was genuine, one vendor responded: “You can’t be sure.” Another provided a photo of a alleged testing documentation. None asked about body mass, health issues or previous experience.

Item Information and Costs

Within these communities, posts show dark colored parcels with postal service stickers, stating to include fresh supplies. One message read: “It took eight of us to load them this morning.”

Customers can choose between powder vials, mixed at residence with purified liquid, or pre-filled injectors typically sold at £160 for 20 milligrams. When asked how much time a pen should last, vendors give conflicting answers ranging from a few weeks to “depends on your body”.

Service Oversight and Security Actions

A representative for the messaging service stated it actively moderated harmful content on its service including content that encouraged the “misuse of controlled medications”. The company added that it removed “millions of pieces of harmful content each day”.

Healthcare Expert Warnings

“Individuals are administering materials they can’t verify. Although the science behind this drug is valid, these online versions may not include what they advertise,” stated a pharmacy expert, the head of pharmacy at a pharmacy service.

Dr Crystal Wyllie of an online medical service linked the increase in demand to current cost increases for authorized weight-loss drugs such as Mounjaro. “With costs rising, patients are turning to online platforms. But fake treatments are highly dangerous. You can’t be certain what’s contained or whether the conditions they were produced in was clean,” she said.

Her staff has already seen patients harmed by self-injection from unverified suppliers. “We recognize the frustration, but buying from messaging apps or WhatsApp is taking chances with your health,” stated Wyllie. “These materials could be impure or improperly measured.”

Producer Statement

A representative from Eli Lilly stated the substance was in third stage research studies and had not been evaluated or approved by any government authority globally. “Consequently at this time no one can sell [it] for human use,” they explained, noting that any product “falsely representing itself as a Lilly experimental product not yet authorized … may subject users to possibly significant health risks”.